Compare Intikeramik Alamasri Industri Tbk. (IKAI) vs Millennium Pharmacon International Tbk. (SDPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intikeramik Alamasri Industri Tbk. vs Millennium Pharmacon International Tbk. — how do they compare? Intikeramik Alamasri Industri Tbk. trades at Rp21 (market cap 279.42B, 9.17M 24h volume), while Millennium Pharmacon International Tbk. trades at Rp185 (market cap 238.24B, 111.3K 24h volume). The key difference: Intikeramik Alamasri Industri Tbk. is the larger of the two by market cap, and Intikeramik Alamasri Industri Tbk. is more actively traded (9.17M versus 111.3K). Which is the better fit depends on your goals.
| IKAI | SDPC | |
|---|---|---|
Market Cap | 279.42B | 238.24B |
Volume | 9.17M | 111.3K |
Lot | 91.73K | 1.11K |
Turnover | 189.5M | 20.36M |
Average Price | 20.66 | 182.91 |
Value | 189.5M | 20.36M |
Indicative Equilibrium Price | 21 | — |
Indicative Equilibrium Volume | 21.35K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intikeramik Alamasri Industri Tbk.
PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Read more on IKAI →About Millennium Pharmacon International Tbk.
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →
